Cryptolepis sanguinolenta: An ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent

Diabetic Medicine

Volumn 15, Issue 5, 1998, Pages 367-374

  Luo, J ^a   Fort, D M ^a   Carlson, T J ^a   Noamesi, B K ^a   Nii Amon Kotei, D ^a   King, S R ^a   Tsai, J ^a   Quan, J ^a   Hobensack, C ^a   Lapresca, P ^a   Waldeck, N ^a   Mendez, C D ^a   Jolad, S D ^a   Bierer, D E ^a   Reaven, G M ^a  

^a Shaman Pharmaceuticals Inc   (United States)

Author keywords

Antihyperglycaemic agents; Cryptolepis sanguinolenta; Drug discovery; Ethnobotany; Ethnomedicine; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; CRYPTOLEPINE; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; INSULIN RELEASE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION;

CRYPTOLEPIS SANGUINOLENTA;

EID: 0008450437     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199805)15:5<367::AID-DIA576>3.0.CO;2-G     Document Type: Article

References (12)

1. Farnsworth NR. The role of ethnopharmacology in drug development. In: Chadwick DJ, Marsh J, eds. Bioactive Compounds from Plants. Ciba Foundation Symposium 154. Chichester/New York: Wiley, 1990: 2-11.
2. Farnsworth NR. Ethnopharmacology and drug development. In Chadwick DJ, Marsh J, eds. Ethnobotany and the Search for New Drugs. Ciba Foundation Symposium 185, Chichester/New York: Wiley, 1994: 24-51.
3. Oliver Bever B, Zahnd GR. Plants with oral hypoglycemic action. Quarterly Journal of Crude Drug Research 1979; 17: 139-196.
4. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989; 12: 553-564.
5. Ivorra MD, Paya M, Villa A. A review of natural products and plants as potential antidiabetic drugs. Journal of Ethnopharmacology 1989; 27: 243-275.
6. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine 1995; 2: 137-189.
7. Oubré AY, Carlson TJ, King SR, Reaven GM. From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia 1997; 40: 614-617.
8. Ampofo O. In: Boakye-Yiadom K, Bambose SOA, eds. Proceedings of First International Seminar on Cryptolepine. Kumasi, Ghana: University of Science and Technology, 1983: 11.
9. Iwu MM. Handbook of African Medicinal Plants. Boca Raton, Florida: CRC Press 1993: 164.
10. Ablordeppey SY, Hufford CD, Borne RF, Dwuma-Badu D. Plant Medica 1990; 56: 416-417.
11. Paulo A, Duarte A, Gomez ET. In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids. J Ethnopharmacol 1994; 44: 127-130.
12. King H. The epidemic of NIDDM: an epidemiological perspective. Int Diab Fed Bull 1995; 40: 10-13.